• January 28, 2009
    DURHAM, N.C.--An ever-growing world population, coupled with increasing feed costs and production pressures, will make demands on the global poultry industry greater than ever in years ahead. Poised to meet those demands is the Poultry Health Division of Pfizer Animal Health (PPH), a hybrid of engineering and poultry animal health technology and innovation that was born via the acquisition of Embrex, Inc. by Pfizer Animal Health in 2007more...
  • March 18, 2008
    NEW YORK--(BUSINESS WIRE)--Pfizer Animal Health today announced it will acquire two market-leading livestock genomics companies: Catapult Genetics, Pty., Ltd., focused on developing and commercializing innovative livestock DNA tests and gene markers to assist global food producers, processors and retailers in improving profitability and quality in the global food chain; and Bovigen, LLC, which markets DNA technology, including Catapult’s productsmore...
  • January 24, 2008
    DURHAM, N.C.--The move follows the takeover of Embrex by Pfizer last year. The new poultry health division is designed to improve health productivity and costs in the poultry industry. Pfizer said that the Poultry Health Division will aim to improve their current products while developing new and integrated poultry health solutions. The division will aim to provide science, solutions, service and success, said Jimmore...
  • January 23, 2008
    DURHAM, N.C.--In ovo, or “in the egg” vaccination has been proven to be the most consistent and effective way to protect birds from disease. The Embrex® Inovoject® System delivers a precise, uniform injection to every egg, every time, offering the most versatile and reliable in ovo delivery platform available. “The Inovoject System has been in use for over 15 years and vaccinates over 35 million eggs per day worldwide,” says Jason Fryarmore...
  • January 23, 2008
    DURHAM, N.C.--Embrex® has been known worldwide for its industry leading customer service, and the new Poultry Health Division of Pfizer Animal Health is committed to providing the same exceptional service that customers have grown to trust. “The company is extremely service oriented,” says Dr. Don Ritter, Veterinarian at Mountaire Farms, a leading vertically-integrated poultry processor servicing customers from the United States andmore...
  • January 23, 2008
    DURHAM, N.C.--Human flu and the vaccines used to prevent it are a major focus in today’s medical world. The Poultry Health Division of Pfizer Animal Health supplies two device platforms for use in human flu vaccine manufacturing facilities –– The Embrex® Inovoject® Systems; Egg Remover® and the Embrex® Inovoject® System. Human flu vaccine is produced in eggs. The Egg Remover is used to provide an accurate, automatic and fast means of removingmore...
  • January 23, 2008
    DURHAM, N.C.--The Poultry Health Division of Pfizer Animal Health provides innovative solutions to improve the health, productivity, and costs of the poultry industry. “Pfizer is excited about delivering innovative poultry health solutions,” says Jim Gerardot, Group Director of Global Marketing, EuAfME, Latin America and Mexico Commercial Operations. The total product offerings from the Poultry Health Division of Pfizermore...
  • January 19, 2007
    NEW YORK--Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) today announced the completion of its acquisition of Embrex, Inc. (Nasdaq: EMBX), an international agricultural biotechnology company known for its Inovoject(R) vaccine-delivery systems. Completion followed the Embrex shareholder meeting today at which Embrex shareholders approved the merger. The transaction has an aggregate equity purchase price of approximately $155 millionmore...
  • December 12, 2006
    RESEARCH TRIANGLE PARK, N.C.--Embrex(R), Inc., The In Ovo Company(R), (Nasdaq: EMBX) announced that a special meeting of its shareholders will be held on January 19, 2007 at 9:00 a.m. local time at its corporate headquarters at 1040 Swabia Court, Durham, North Carolina 27703 to consider and vote upon a proposal to approve and adopt the Agreement and Plan of Merger dated as of November 14, 2006, among Embrex, Inc., Pfizer Inc. and Eagle Mergermore...
  • November 15, 2006
    NEW YORK & RESEARCH TRIANGLE PARK, N.C.--Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) has agreed to acquire Embrex, Inc. (NASDAQ: EMBX), an international agricultural biotechnology company known for its Inovoject® vaccine-delivery systems, the companies announced today. Under the terms of the agreement, Pfizer will acquire through a merger 100 percent of the equity of Embrex for $17 per share in cash, makingmore...